1. Home
  2. SEZL vs GRFS Comparison

SEZL vs GRFS Comparison

Compare SEZL & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sezzle Inc.

SEZL

Sezzle Inc.

HOLD

Current Price

$110.86

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.43

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEZL
GRFS
Founded
2016
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.0B
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
SEZL
GRFS
Price
$110.86
$7.43
Analyst Decision
Buy
Hold
Analyst Count
6
2
Target Price
$109.33
$10.15
AVG Volume (30 Days)
361.9K
358.8K
Earning Date
05-06-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
2.64
N/A
Revenue
$450,279,000.00
N/A
Revenue This Year
$30.30
$4.49
Revenue Next Year
$24.79
$6.42
P/E Ratio
$44.15
$18.67
Revenue Growth
66.08
N/A
52 Week Low
$49.50
$6.96
52 Week High
$195.71
$10.23

Technical Indicators

Market Signals
Indicator
SEZL
GRFS
Relative Strength Index (RSI) 43.47 39.33
Support Level $112.53 $7.26
Resistance Level $122.31 $8.41
Average True Range (ATR) 4.60 0.11
MACD 0.94 -0.04
Stochastic Oscillator 37.90 13.87

Price Performance

Historical Comparison
SEZL
GRFS

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: